Betteridge D. John: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

What is oxidative stress?

D. John Betteridge

Journal:

Year:

2000

Language:

english

File:

PDF, 571 KB

english, 2000

2

Comparison of Effectiveness of Rosuvastatin Versus Atorvastatin on the Achievement of Combined C-Reactive Protein (

D. John Betteridge, J. Martin Gibson, Philip T. Sager

Journal:

The American Journal of Cardiology

Year:

2007

Language:

english

File:

PDF, 128 KB

english, 2007

3

Pitavastatin – results from phase III & IV

Betteridge, John

Journal:

Atherosclerosis Supplements

Year:

2010

Language:

english

File:

PDF, 99 KB

english, 2010

4

Fasting and postprandial determinants for the occurrence of small dense LDL species in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia: the involvement of insulin, insulin precursor species and insulin resistance

Kathryn C.B. Tan, Michael B. Cooper, K.L.Eddie Ling, Bruce A. Griffin, Dilys J. Freeman, Christopher J. Packard, James Shepherd, C.Nicholas Hales, D.John Betteridge

Journal:

Atherosclerosis

Year:

1995

Language:

english

File:

PDF, 1.46 MB

english, 1995

5

Solid-Phase Extraction and LC−MS Analysis of Pyrrolizidine Alkaloids in Honeys

Beales, Kerrie A., Betteridge, Keith, Colegate, Steven M., Edgar, John A.

Journal:

Journal of Agricultural and Food Chemistry

Year:

2004

Language:

english

File:

PDF, 208 KB

english, 2004

6

Mo1713 Predictors of a Complicated Disease Course in Crohn's Disease

Patil, Seema, Flasar, Mark, Rustgi, Ankur, Watson, Joshua T., Betteridge, John, Szeto, Winnie, Cheevers, Nadia, Yang, Mei, Chao, Jingdong, Mulani, Parvez, Cross, Raymond

Journal:

Gastroenterology

Year:

2012

Language:

english

File:

PDF, 137 KB

english, 2012

7

The safety and tolerability of atorvastatin 10 mg in the Collaborative Atorvastatin Diabetes Study (CARDS)

Newman, Connie B, Szarek, Michael, Colhoun, Helen M, Betteridge, D John, Durrington, Paul N, Hitman, Graham A, Neil, H Andrew W, Demicco, David A, Auster, Sheila, Fuller, John H

Journal:

Diabetes and Vascular Disease Research

Year:

2008

Language:

english

File:

PDF, 80 KB

english, 2008

8

The diabetogenic action of statins — mechanisms and clinical implications

Betteridge, D. John, Carmena, Rafael

Journal:

Nature Reviews Endocrinology (formerly Nature Clinical Practice Endocrinology & Metabolism)

Year:

2015

Language:

english

File:

PDF, 814 KB

english, 2015

9

Inflammatory Bowel Disease Prevalence by Age, Gender, Race, and Geographic Location in the U.S. Military Health Care Population

Betteridge, John D., Armbruster, Steven P., Maydonovitch, Corinne, Veerappan, Ganesh R.

Journal:

Inflammatory Bowel Diseases

Year:

2013

Language:

english

File:

PDF, 321 KB

english, 2013

10

Familial lipoprotein lipase (LPL) deficiency: A catalogue of LPL gene mutations identified in 20 patients from the UK, Sweden, and Italy

France Mailly, Jutta Palmen, David P. R. Muller, Tracy Gibbs, June Lloyd, John Brunzell, Paul Durrington, Kostas Mitropoulos, John Betteridge, Gerald Watts, Hans Lithell, Franco Angelico, Steve E. Hum

Journal:

Year:

1997

Language:

english

File:

PDF, 232 KB

english, 1997

11

Simulation der Chemie von Zeolithen mit Computer-Graphik

Dr. Subramaniam Ramdas, Prof. Dr. John M. Thomas, P. W. Betteridge, Dr. Anthony K. Cheetham, E. K. Davies

Journal:

Angewandte Chemie

Year:

1984

Language:

german

File:

PDF, 5.91 MB

german, 1984

12

Modelling the Chemistry of Zeolites by Computer Graphics

Dr. Subramaniam Ramdas, Prof. Dr. John M. Thomas, Paul W. Betteridge, Dr. Anthony K. Cheetham, Dr. E. Keith Davies

Journal:

Angewandte Chemie International Edition

Year:

1984

Language:

english

File:

PDF, 1.38 MB

english, 1984

13

The use of Pholasin® as a probe for the determination of plasma total antioxidant capacity

Nourooz-Zadeh Jaffar, Ziegler Dan, Sohr Christopher, Betteridge D. John, Knight Jan, Hothersall John

Journal:

Clinical Biochemistry

Year:

2006

Language:

english

File:

PDF, 392 KB

english, 2006

14

Corrigendum to “The use of Pholasin® as a probe for the determination of plasma total antioxidant capacity” [Clin Biochem 39 (2006) 55–61]

Jaffar Nourooz-Zadeh, Dan Ziegler, Christopher Sohr, John D. Betteridge, Jan Knight, John Hothersall

Journal:

Clinical Biochemistry

Year:

2007

Language:

english

File:

PDF, 76 KB

english, 2007

15

Spectrophotometric determination of thallium as thallium tetriodide

D. Betteridge, John H. Yoe

Journal:

Analytica Chimica Acta

Year:

1962

Language:

english

File:

PDF, 594 KB

english, 1962

16

Evaluation of methods for the extraction of nitrite and nitrate in biological fluids employing high-performance anion-exchange liquid chromatography for their determination

Christopher C.T Smith, Lee Stanyer, D.John Betteridge

Journal:

Journal of Chromatography B

Year:

2002

Language:

english

File:

PDF, 251 KB

english, 2002

17

Diabetic dyslipidaemia

D. John Betteridge

Journal:

Diabetes, Obesity and Metabolism

Year:

2000

Language:

english

File:

PDF, 61 KB

english, 2000

18

Diabetes lipids and atherosclerosis

John Betteridge

Journal:

Practical Diabetes

Year:

1984

Language:

english

File:

PDF, 469 KB

english, 1984

19

Dyslipidaemia and diabetes

Professor D. John Betteridge

Journal:

Practical Diabetes

Year:

2001

Language:

english

File:

PDF, 123 KB

english, 2001

20

Is the current therapeutic armamentarium in diabetes enough to control the epidemic and its consequences? What are the current shortcomings?

Dario Giugliano, Eberhard Standl, Tina Vilsbøll, John Betteridge, Riccardo Bonadonna, Ian W. Campbell, Gerit-Holger Schernthaner, Bart Staels, Antonia Trichopoulou, Eduardo Farinaro

Journal:

Acta Diabetologica

Year:

2009

Language:

english

File:

PDF, 226 KB

english, 2009

21

Introduction

D. John Betteridge

Journal:

Acta Diabetologica

Year:

2002

Language:

english

File:

PDF, 24 KB

english, 2002

22

Treatment of lipid disorders in patients with diabetes

Helen M. Colhoun, David John Betteridge

Journal:

Current Treatment Options in Cardiovascular Medicine

Year:

2006

Language:

english

File:

PDF, 355 KB

english, 2006

23

Reduced postprandial proinsulinaemia and 32–33 split proinsulinaemia after a mixed meal in type 2 diabetic patients following sensitization to insulin with pioglitazone

Michael B. Cooper, Khulood Al Majali, Clifford J. Bailey, D. John Betteridge

Journal:

Clinical Endocrinology

Year:

2008

Language:

english

File:

PDF, 248 KB

english, 2008

24

Effects of pioglitazone on lipid and lipoprotein metabolism

D. John Betteridge

Journal:

Diabetes, Obesity and Metabolism

Year:

2007

Language:

english

File:

PDF, 90 KB

english, 2007

25

CHICAGO, PERISCOPE and PROactive: CV risk modification in diabetes with pioglitazone

D. John Betteridge

Journal:

Fundamental & Clinical Pharmacology

Year:

2009

Language:

english

File:

PDF, 66 KB

english, 2009

26

Circulating vitamin E, transforming growth factor beta1, and the association with renal disease susceptibility in two racial groups with type 2 diabetes

Zitouni, Karima, Harry, Diane D., Nourooz-Zadeh, Jaffar, Betteridge, D. John, Earle, Kenneth A.

Journal:

Kidney International

Year:

2005

Language:

english

File:

PDF, 115 KB

english, 2005

27

Delayed hypersensitivity reaction with infliximab: Unusual to occur after initial dose

Mazer R. Ally, John D. Betteridge, Ganesh R. Veerappan

Journal:

Inflammatory Bowel Diseases

Year:

2012

Language:

english

File:

PDF, 42 KB

english, 2012

28

Pulmonary carcinoid tumor in a patient on adalimumab for Crohn's disease

John D. Betteridge, Ganesh R. Veerappan

Journal:

Inflammatory Bowel Diseases

Year:

2012

Language:

english

File:

PDF, 723 KB

english, 2012

29

Statins: the key trials

Professor John Betteridge

Journal:

Trends in Urology & Men's Health

Year:

2011

Language:

english

File:

PDF, 1.13 MB

english, 2011

30

The statins: a drug class to celebrate

Professor John Betteridge

Journal:

Trends in Urology & Men's Health

Year:

2010

Language:

english

File:

PDF, 122 KB

english, 2010

31

The influence of aspirin on plasma and platelet catecholamine levels, and platelet function in normal man

Christopher C. T. Smith, Anne P. Wilson, D. John Betteridge

Journal:

Clinical Autonomic Research

Year:

1993

Language:

english

File:

PDF, 521 KB

english, 1993

32

Probiotics for the Treatment of Inflammatory Bowel Disease

Veerappan, Ganesh R., Betteridge, John, Young, Patrick E.

Journal:

Current Gastroenterology Reports

Year:

2012

Language:

english

File:

PDF, 192 KB

english, 2012

33

Long-Term Lipid Effects of Pioglitazone by Baseline Anti-Hyperglycemia Medication Therapy and Statin Use from the PROactive Experience (PROactive 14)

Robert Spanheimer, D. John Betteridge, Meng H. Tan, Ele Ferrannini, Bernard Charbonnel

Journal:

The American Journal of Cardiology

Year:

2009

Language:

english

File:

PDF, 399 KB

english, 2009

34

Platelet secretion of β-amyloid is increased in hypercholesterolaemia

Christopher C.T. Smith, Penelope J. Hyatt, Lee Stanyer, D.John Betteridge

Journal:

Year:

2001

Language:

english

File:

PDF, 207 KB

english, 2001

35

Effects of Atorvastatin on Kidney Outcomes and Cardiovascular Disease in Patients With Diabetes: An Analysis From the Collaborative Atorvastatin Diabetes Study (CARDS)

Helen M. Colhoun, D. John Betteridge, Paul N. Durrington, Graham A. Hitman, H. Andrew W. Neil, Shona J. Livingstone, Valentine Charlton-Menys, David A. DeMicco, John H. Fuller

Journal:

American Journal of Kidney Diseases

Year:

2009

Language:

english

File:

PDF, 280 KB

english, 2009

36

Bone mineral density in thyroxine treated females with or without a previous history of thyrotoxicosis

Jayne Franklyn, Joan Betteridge, Roger Holder, Jacquie Daykin, John Lilley, Michael Sheppard

Journal:

Clinical Endocrinology

Year:

1994

Language:

english

File:

PDF, 660 KB

english, 1994

37

Effect of intensive lipid-lowering therapy on cardiovascular outcome in patients with and those without inflammatory joint disease

Anne Grete Semb, Tore K. Kvien, David A. DeMicco, Rana Fayyad, Chuan-Chuan Wun, John C. LaRosa, John Betteridge, Terje R. Pedersen, Ingar Holme

Journal:

Arthritis & Rheumatism

Year:

2012

Language:

english

File:

PDF, 95 KB

english, 2012

38

Enhanced in vivo platelet release reaction and malondialdehyde formation in patients with hyperlipidemia

Joseph Zahavi, John D. Betteridge, Nigel A.G. Jones, David J. Galton, Vijay V. Kakkar

Journal:

The American Journal of Medicine

Year:

1981

Language:

english

File:

PDF, 760 KB

english, 1981

39

Diabetic dyslipidemia

D.John Betteridge

Journal:

The American Journal of Medicine

Year:

1994

Language:

english

File:

PDF, 911 KB

english, 1994

40

Regulation of sterol synthesis in human lymphocytes: Evidence for post-transcriptional control by low density lipoprotein

Wilhelm Krone, D. John Betteridge, David J. Galton

Journal:

Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism

Year:

1979

Language:

english

File:

PDF, 378 KB

english, 1979

41

Benefits of lipid-lowering therapy in patients with type 2 diabetes mellitus

John Betteridge

Journal:

The American Journal of Medicine

Year:

2005

Language:

english

File:

PDF, 205 KB

english, 2005

42

Potentiation of β-amyloid polymerisation by low-density lipoprotein enhances the peptide's vasoactivity

Lee Stanyer, D.John Betteridge, Christopher C.T. Smith

Journal:

Biochimica et Biophysica Acta (BBA) - General Subjects

Year:

2004

Language:

english

File:

PDF, 392 KB

english, 2004

43

Exaggerated polymerisation of β-amyloid 40 stimulated by plasma lipoproteins results in fibrillar Aβ preparations that are ineffective in promoting ADP-induced platelet aggregation

Lee Stanyer, D. John Betteridge, Christopher C.T. Smith

Journal:

Biochimica et Biophysica Acta (BBA) - General Subjects

Year:

2004

Language:

english

File:

PDF, 229 KB

english, 2004

44

Targeting dyslipidemia—the key to CHD risk reduction in the diabetic population?

D. John Betteridge, Robert S. Rosenson

Journal:

Diabetes Research and Clinical Practice

Year:

2005

Language:

english

File:

PDF, 59 KB

english, 2005

45

Long-term risk reduction: Who needs treatment?

D. John Betteridge

Journal:

Diabetes Research and Clinical Practice

Year:

2005

Language:

english

File:

PDF, 160 KB

english, 2005

46

Soluble β-amyloid (Aβ) 40 causes attenuation or potentiation of noradrenaline-induced vasoconstriction in rats depending upon the concentration employed

Christopher C.T Smith, Lee Stanyer, D.John Betteridge

Journal:

Neuroscience Letters

Year:

2004

Language:

english

File:

PDF, 80 KB

english, 2004

47

Plasma β-amyloid (Aβ) 40 concentration, lipid status and age in humans

Christopher C.T Smith, D.John Betteridge

Journal:

Neuroscience Letters

Year:

2004

Language:

english

File:

PDF, 59 KB

english, 2004

48

An investigation into the mechanisms mediating plasma lipoprotein-potentiated β-amyloid fibrillogenesis

Lee Stanyer, D.John Betteridge, Christopher C.T Smith

Journal:

Year:

2002

Language:

english

File:

PDF, 274 KB

english, 2002

49

A new drug target for treatment of dyslipidaemia associated with type 2 diabetes and the metabolic syndrome?

Rossitza P Naoumova, D John Betteridge

Journal:

Year:

2002

Language:

english

File:

PDF, 56 KB

english, 2002

50

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

Helen M Colhoun, D John Betteridge, Paul N Durrington, Graham A Hitman, H Andrew W Neil, Shona J Livingstone, Margaret J Thomason, Michael I Mackness, Valentine Charlton-Menys, John H Fuller

Journal:

Year:

2004

Language:

english

File:

PDF, 199 KB

english, 2004